ANDREW J MURPHY Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANDREW J MURPHY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANDREW J MURPHY. ANDREW J MURPHY is EVP Research in REGENERON PHARMACEUTICALS, INC. ($REGN).
Latest Insider Trading Transactions of ANDREW J MURPHY
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 11 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Option Exercise | A | 492.00 | 25,000 | 12,300,000 | 25,000 | |
Dec 11 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Grant | A | 0.00 | 1,929 | 0 | 57,350 | 55.4 K to 57.4 K (+3.48 %) |
Dec 11 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Grant | A | 0.00 | 8,285 | 0 | 55,421 | 47.1 K to 55.4 K (+17.58 %) |
Oct 23 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
Oct 23 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Option Exercise | M | 30.63 | 3,264 | 99,976 | 0 | |
Oct 23 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Buy | M | 30.63 | 3,264 | 99,976 | 47,136 | 43.9 K to 47.1 K (+7.44 %) |
Oct 23 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Buy | M | 52.03 | 1,921 | 99,950 | 43,872 | 42 K to 43.9 K (+4.58 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Option Exercise | M | 30.63 | 13,000 | 398,190 | 13,736 | |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 639.55 | 79 | 50,524 | 41,951 | 42 K to 42 K (-0.19 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 638.96 | 239 | 152,711 | 42,030 | 42.3 K to 42 K (-0.57 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 637.48 | 182 | 116,021 | 42,269 | 42.5 K to 42.3 K (-0.43 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 635.46 | 175 | 111,206 | 42,451 | 42.6 K to 42.5 K (-0.41 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 634.18 | 89 | 56,442 | 42,626 | 42.7 K to 42.6 K (-0.21 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 633.02 | 95 | 60,137 | 42,715 | 42.8 K to 42.7 K (-0.22 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 632.12 | 679 | 429,209 | 42,810 | 43.5 K to 42.8 K (-1.56 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 631.32 | 578 | 364,903 | 43,489 | 44.1 K to 43.5 K (-1.31 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 630.77 | 264 | 166,523 | 44,067 | 44.3 K to 44.1 K (-0.60 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 629.58 | 852 | 536,402 | 44,331 | 45.2 K to 44.3 K (-1.89 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 628.50 | 950 | 597,075 | 45,183 | 46.1 K to 45.2 K (-2.06 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 626.66 | 83 | 52,013 | 46,133 | 46.2 K to 46.1 K (-0.18 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 625.05 | 4 | 2,500 | 46,216 | 46.2 K to 46.2 K (-0.01 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 624.77 | 487 | 304,263 | 46,220 | 46.7 K to 46.2 K (-1.04 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 622.51 | 1 | 623 | 46,707 | 46.7 K to 46.7 K (0.00 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 621.06 | 113 | 70,180 | 46,708 | 46.8 K to 46.7 K (-0.24 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 620.94 | 81 | 50,296 | 46,821 | 46.9 K to 46.8 K (-0.17 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 619.28 | 162 | 100,323 | 46,902 | 47.1 K to 46.9 K (-0.34 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 618.39 | 255 | 157,689 | 47,064 | 47.3 K to 47.1 K (-0.54 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 617.64 | 304 | 187,763 | 47,319 | 47.6 K to 47.3 K (-0.64 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 616.34 | 256 | 157,783 | 47,623 | 47.9 K to 47.6 K (-0.53 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 615.59 | 203 | 124,965 | 47,879 | 48.1 K to 47.9 K (-0.42 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 614.62 | 178 | 109,402 | 48,082 | 48.3 K to 48.1 K (-0.37 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Payment of Exercise | F | 623.98 | 6,691 | 4,175,050 | 48,260 | 55 K to 48.3 K (-12.18 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Buy | M | 30.63 | 13,000 | 398,190 | 54,951 | 42 K to 55 K (+30.99 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 633.28 | 441 | 279,276 | 41,951 | 42.4 K to 42 K (-1.04 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 632.65 | 680 | 430,202 | 42,392 | 43.1 K to 42.4 K (-1.58 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 631.45 | 861 | 543,678 | 43,072 | 43.9 K to 43.1 K (-1.96 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 630.50 | 1,423 | 897,202 | 43,933 | 45.4 K to 43.9 K (-3.14 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 629.62 | 883 | 555,954 | 45,356 | 46.2 K to 45.4 K (-1.91 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 628.32 | 259 | 162,735 | 46,239 | 46.5 K to 46.2 K (-0.56 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 627.54 | 657 | 412,294 | 46,498 | 47.2 K to 46.5 K (-1.39 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 626.63 | 1,003 | 628,510 | 47,155 | 48.2 K to 47.2 K (-2.08 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 625.86 | 173 | 108,274 | 48,158 | 48.3 K to 48.2 K (-0.36 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 624.47 | 370 | 231,054 | 48,331 | 48.7 K to 48.3 K (-0.76 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 623.66 | 740 | 461,508 | 48,701 | 49.4 K to 48.7 K (-1.50 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 622.74 | 333 | 207,372 | 49,441 | 49.8 K to 49.4 K (-0.67 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 621.98 | 81 | 50,380 | 49,774 | 49.9 K to 49.8 K (-0.16 %) |
Jul 15 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 620.64 | 96 | 59,581 | 49,855 | 50 K to 49.9 K (-0.19 %) |
Jan 28 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 343.02 | 214 | 73,406 | 49,951 | 50.2 K to 50 K (-0.43 %) |
Jan 28 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 342.44 | 1,399 | 479,074 | 50,165 | 51.6 K to 50.2 K (-2.71 %) |
Jan 28 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 341.58 | 3,283 | 1,121,407 | 51,564 | 54.8 K to 51.6 K (-5.99 %) |
Jan 28 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 340.56 | 1,355 | 461,459 | 54,847 | 56.2 K to 54.8 K (-2.41 %) |
Jan 28 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 339.37 | 567 | 192,423 | 56,202 | 56.8 K to 56.2 K (-1.00 %) |
Jan 28 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 338.54 | 712 | 241,040 | 56,769 | 57.5 K to 56.8 K (-1.24 %) |
Jan 28 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 337.46 | 270 | 91,114 | 57,481 | 57.8 K to 57.5 K (-0.47 %) |
Jan 28 2020 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Sell | S | 336.78 | 200 | 67,356 | 57,751 | 58 K to 57.8 K (-0.35 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Option Exercise | A | 372.46 | 24,500 | 9,125,270 | 24,500 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Grant | A | 0.00 | 10,000 | 0 | 57,951 | 48 K to 58 K (+20.85 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | MURPHY ANDREW J | EVP Research | Grant | A | 0.00 | 2,625 | 0 | 47,951 | 45.3 K to 48 K (+5.79 %) |
Page: 1